endocrinologist glp 1 Weight loss is often the goal for those taking GLP-1 medications. But in some cases, people shed more than just pounds. They also lose hair. Listen in as Kathy Zhou explains Long-Term Effects Of GLP-1s: Risks

The Lancet (online 12 September 2014).

The STEP trials evaluated semaglutide and showed average weight reductions of around 15% over 68 weeks, while SURMOUNT trialsfocusing on tirzepatide, a dual GIP/GLP-1 receptor agonistdemonstrated even greater reductions, with participants losing up to 21% of their body weight over 72 weeks (Note: GIP = Glucose-dependent insulinotropic polypeptide)

it was like the lifting of a veil

The therapy generated approximately USD 8 billion in U.S

If you contact your plan, please call your pharmacy benefit manager (PBM) as they will handle the prior authorization for your prescription and not your medical insurance network